iShares Nasdaq Biotechnology ETF


Добавить в список отслеживания Добавить в список отслеживания
Добавить в портфель Добавить в портфель

Основные параметры

Цена последней сделки 156.37
Код ценной бумаги IBB
Полное наименование iShares Nasdaq Biotechnology ETF
Объем 10873000000
Изм за день, % -0.02
Комиссия 0.46
Дата основания Feb 05. 2001
Ссылка ссылка
Тип актива Equity
Индекс NASDAQ Biotechnology Index
Регион North America
Средний P/E 20.82
Дивиденды 0.19
5 летняя доходность 78.80
3 летняя доходность 46.97
Годовая доходность 31.26
Бета 0.97
Валюта usd
Топ 10 эмитентов, % 42.52
Количество компаний 283

Топ эмитентов

Эмитент Доля, % P/BV P/S P/E EV/Ebitda
Amgen 7.54 13.89 5.13 18.36 12.06
Gilead Sciences 6.26 4.34 3.2 642.55 8.03
Illumina 5.08 13.71 19.86 99.06 76.42
Moderna 4.99 23.12 73.91 -80
Vertex 4.5 6.35 8.89 20.63 16.44
Regeneron 3.85 4.35 5.95 15.13 13.41
Biogen 3.42 3.88 3.09 11 9.16
Alexion 2.73 2.86 5.49 55.76 10.45
Seagen 2.22 7.97 12.8 45.61 38.74
AstraZeneca PLC 1.93 8.13 4.8 39.72 20.95
Horizon Therapeutics Public Limited Company 1.64 5.2 9.62 52.22 34.88
Incyte 1.4 6.65 6.52 47.64 -84.07
Alnylam Pharmaceuticals, Inc. 1.4 17.03 35.28 -20.13
BeiGene, Ltd. 1.23 7.28 94.32 -15.48

Похожие ETF

Описание iShares Nasdaq Biotechnology ETF

This ETF offers exposure to the biotech sub-sector of the health care industry, serving up access to a group of stocks that can thrive on technological breakthroughs and increased investment in medical processes. IBB is primarily focused on U.S. stocks, though a smattering of international firms adds some degree of international diversification. This biotech ETF casts a considerably wider net that the other ETF options for exposure to the space, investing in more than 100 stocks. That feature can be particularly important in the biotech space, where company-specific developments can send a single stock soaring. IBB is somewhat top-heavy, but generally spreads exposure across large caps, mid caps, and small cap stocks. PBE and FBT are other ETF options for biotech exposure; those considering this sector should take a close look at depth of exposure and weighing methodology, as these factors can have a major impact on the risk and return profiles achieved. The expense differentials are also worth noting; IBB is the most attractive in this respect.